XML 25 R10.htm IDEA: XBRL DOCUMENT v3.22.2
Note 4 - Discontinued Operations
12 Months Ended
Mar. 31, 2022
Notes to Financial Statements  
Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]

Note 4 - Discontinued Operations

 

Discontinued Operations

 

Discontinued operations comprise those activities that were disposed of during the period, or which were classified as held for sale at the end of the period and represent a separate major line of business or geographical area that can be clearly distinguished for operational and financial reporting purposes. The Company has included its subsidiaries GB Sciences Nevada, LLC, GB Sciences Las Vegas, LLC, and GB Sciences Nopah, LLC in discontinued operations due to the sale of the Company's Nevada Subsidiaries (Note 13).

 

The assets and liabilities associated with discontinued operations included in our consolidated balance sheets as of  March 31, 2022 and 2021 were as follows:

 

  

March 31, 2022

  

March 31, 2021

 
  

Continuing

  

Discontinued Nevada Subsidiaries

  

Total

  

Continuing

  

Discontinued Nevada Subsidiaries

  

Total

 

ASSETS

                        

CURRENT ASSETS

                        

Cash

 $233,893  $-  $233,893  $793,040  $352,593  $1,145,633 

Accounts receivable, net

  -   -   -   -   400,175   400,175 

Inventory, net

  -   -   -   -   1,689,304   1,689,304 

Prepaid and other current assets

  93,933   -   93,933   256,251   52,492   308,743 

TOTAL CURRENT ASSETS

  327,826   -   327,826   1,049,291   2,494,564   3,543,855 
                         

Property and equipment, net

  -   -   -   25,022   4,876,247   4,901,269 

Intangible assets, net

  2,222,074   -   2,222,074   1,706,762   571,264   2,278,026 

Deposits and other noncurrent assets

  -   -   -   -   82,904   82,904 
                         

TOTAL ASSETS

 $2,549,900  $-  $2,549,900  $2,781,075  $8,024,979  $10,806,054 
                         

LIABILITIES

                        

CURRENT LIABILITIES

                        

Accounts payable

 $1,657,008  $-  $1,657,008  $1,412,459  $509,477  $1,921,936 

Accrued interest

  384,769   -   384,769   493,741   49,211   542,952 

Accrued liabilities

  9,627   -   9,627   957,946   105,421   1,063,367 

Notes and convertible notes payable, net

  987,565   -   987,565   3,594,804   485,000   4,079,804 

Indebtedness to related parties

  -   -   -   84,913   -   84,913 

Income tax payable

  896,495   -   896,495   761,509   -   761,509 

Finance lease obligations, current

  -   -   -   -   143,967   143,967 

TOTAL CURRENT LIABILITIES

  3,935,464   -   3,935,464   7,305,372   1,293,076   8,598,448 
                         

Convertible notes payable, net

  397,308   -   397,308   292,410   -   292,410 

Finance lease obligations, long term

  -   -   -   -   3,389,124   3,389,124 
                         

TOTAL LIABILITIES

 $4,332,772  $-  $4,332,772  $7,597,782  $4,682,200  $12,279,982 

 

The revenues and expenses associated with discontinued operations included in our consolidated statements of operations for the years ended  March 31, 2022 and 2021, were as follows:

 

  

For the Year Ended March 31,

  

For the Year Ended March 31,

 
  

2022

  

2021

 
  

Continuing

  

Discontinued - Nevada

  

Total

  

Continuing

  

Discontinued - Nevada

  

Total

 

Sales revenue

 $-  $3,369,812  $3,369,812  $-  $4,110,456  $4,110,456 

Cost of goods sold

  -   (3,072,622)  (3,072,622)  -   (3,506,722)  (3,506,722)

Gross profit (loss)

  -   297,190   297,190   -   603,734   603,734 

General and administrative expenses

  1,868,734   264,515   2,133,249   2,001,617   276,986   2,278,603 

LOSS FROM OPERATIONS

  (1,868,734)  32,675   (1,836,059)  (2,001,617)  326,748   (1,674,869)

OTHER INCOME/(EXPENSE)

                        

Gain on extinguishment

  22,405   -   22,405   467,872   -   467,872 

Gain on settlement of accounts payable

  -   -   -   422,414   54,958   477,372 

Gain on deconsolidation

  5,206,208   -   5,206,208   -   -   - 

Interest expense

  (474,768)  (302,923)  (777,691)  (1,285,460)  (486,481)  (1,771,941)

Loss on modification of line of credit

  -   -   -   (650,000)  -   (650,000)

Loss on impairment of note receivable

  (3,025,000)  -   (3,025,000)  -   -   - 

Debt default penalty

  -   -   -   (286,059)  -   (286,059)

Loss on disposal

  (15,639)  -   (15,639)  -   -   - 

Other income

  9,000   20,889   29,889   -   (118,875)  (118,875)

TOTAL OTHER INCOME/(EXPENSE)

  1,722,206   (282,034)  1,440,172   (1,331,233)  (550,398)  (1,881,631)

NET LOSS BEFORE INCOME TAXES

  (146,528)  (249,359)  (395,887)  (3,332,850)  (223,650)  (3,556,500)

Income tax expense

  -   (134,986)  (134,986)  -   (168,527)  (168,527)

NET LOSS

 $(146,528) $(384,345) $(530,873) $(3,332,850) $(392,177) $(3,725,027)

 

Discontinued Operations - Accounts Receivable

 

Accounts receivable are carried at their estimated collectible amounts. Trade accounts receivable are periodically evaluated for collectability based on aging and subsequent collections. There were no accounts receivable at March 31, 2022 due to the deconsolidation of the Nevada Subsidiaries (Note 13). Accounts receivable are included in current assets from discontinued operations in the Company's consolidated balance sheet at March 31, 2021.

 

Discontinued Operations - Inventory

 

We value inventory at the lower of the actual cost of our inventory, as determined using the first-in, first-out method, or its current estimated market value. We periodically review our physical inventory for excess, obsolete, and potentially impaired items and reserve accordingly. Our reserve estimate for excess and obsolete inventory is based on expected future use. Indirect costs, which primarily related to the lease and operation costs of the Teco Facility, are allocated based on square footage of the facility used in the production of inventory.

 

Raw materials consist of supplies, materials, and consumables used in the cultivation and extraction processes. Work-in-progress consisted of live plants and cannabis in the drying, curing, and trimming processes. Finished goods includes completed cannabis flower, trim, and extracts in bulk and packaged forms. There is no remaining inventory on the Company's consolidated balance sheet as of March 31, 2022, due to the sale and deconsolidation of the Nevada Subsidiairies (Note 13). Inventory is included in current assets from discontinued operations in the Company's consolidated balance sheet at March 31, 2021.

 

 

  

March 31, 2022

  

March 31, 2021

 

Inventory (discontinued operations)

        

Raw materials

 $-  $86,076 

Work in progress

  -   743,844 

Finished goods

  -   866,195 

Subtotal

  -   1,696,115 

Allowance to reduce inventory to NRV

  -   (6,811)

Total inventory (discontinued operations)

 $-  $1,689,304 

 

Discontinued Operations - Deposits and Noncurrent Assets

 

Deposits and noncurrent assets from discontinued operations were $82,904 at March 31, 2021. There were no deposits and noncurrent assets from discontinued operations at March 31, 2022, due to the deconsolidation of the Nevada Subsidiaries.  Deposits and noncurrent assets are included in long term assets from discontinued operations in the Company's consolidated balance sheet at March 31, 2021.

 

Discontinued Operations - Leases

 

The Company evaluates all finance and operating leases, and they are measured on the balance sheet with a lease liability and right-of-use asset (“ROU”) at inception. ROU assets represent the Company’s right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make scheduled lease payments. Lease terms include options to extend when it is reasonably certain that the option will be exercised. Leases with a term of 12 months or less are not recorded on the consolidated balance sheet. The present value of lease payments is calculated using the incremental borrowing rate at lease commencement, which takes into consideration recent debt issuances as well as other applicable market data available.

 

The Company's only remaining lease commitment was a finance lease for the Nevada Subsidiaries, which is classified as discontinued operations in the Company's consolidated balance sheet at March 31, 2021. This lease had a remaining non-cancelable term ending December 31, 2025 with an option to extend through December 31, 2030. The rate used to discount this lease was 11.5%.

 

Finance leases are included in property and equipment (long term assets from discontinued operations), finance lease obligations, short term (current liabilities from discontinued operations), and finance lease obligations, long term (long term liabilities from discontinued operations), on the balance sheet as of March 31, 2021.

 

The right-of-use asset and lease liability were deconsolidated at December 31, 2021 due to the close of the sale of the Nevada Subsidiaries. The lease costs included in discontinued operations for the years ended  March 31, 2022 and 2021 are set forth in the table below:

 

 

   

March 31,

 

Lease costs (discontinued operations)

Classification on the Statements of Operations

  2022   2021 

Discontinued operations:

         

Finance leases - amortization of ROU assets

Loss from discontinued operations

 $116,024  $154,699 

Finance leases - interest on lease liabilities

Loss from discontinued operations

  301,796   414,993 

Operating leases

Loss from discontinued operations

  -   3,243 

Total lease cost, discontinued operations

 $417,820  $572,935 

 

 

Discontinued Operations - 8% Line of Credit dated November 27, 2019

 

In connection with the Binding Letter of Intent dated November 27, 2019 (Note 13), the Teco Subsidiaries entered into a promissory note and line of credit for up to $470,000 from the purchaser of the membership interests in the Teco Subsidiaries. The purpose of the line of credit was to supply working capital for the Teco Subsidiaries, and the note matures upon the close of the sale of the Teco Subsidiaries. The principal and accrued interest balances outstanding at the time of closing will be considered paid in full upon closing and will not reduce the purchase price received by GB Sciences. In total, the Teco Subsidiaries received $485,000 in advances under the line of credit, reflecting an informal agreement with the lender to increase the line of credit by $15,000. On December 29, 2020, the Company entered into the Omnibus Amendment with the purchaser of the Teco Facility, which provided that no further interest would accrue on the line of credit after November 30, 2020. The balance of the line of credit was $485,000 at  December 31, 2021 and accrued interest was $49,211, prior to deconsolidation. The note and related interest expense are included in current liabilities from discontinued operations and loss from discontinued operations on the Company's March 31, 2021 balance sheet.